27 March 2021 : Clinical Research
Use of the Water-Soluble Contrast Medium Gastrografin in Treatment of Adhesive Small Bowel Obstruction in Patients with and Without Chronic Radiation Enteropathy: A Single-Center Retrospective Study
Lili Gu1BCEF, Feng Zhu1BDE, Tingbin Xie1BCD, Dengyu Feng1BEF, Jianfeng Gong1BDEG, Ning Li2ABEFG*DOI: 10.12659/MSM.930046
Med Sci Monit 2021; 27:e930046
Table 6 Multivariable model for features associated with successful non-operative management in patients with and without Gastrografin challenge.
| Feature | GG challenge (n=30) | No GG challenge (n=30) | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI | p | OR | 95% CI | p | |
| Age | 0.93 | 0.87–1.21 | 0.32 | 0.82 | 0.53–1.29 | 0.429 |
| Male sex | 2.31 | 0.78–5.89 | 0.129 | 0.95 | 0.88–1.02 | 0.265 |
| Radiologic signs | ||||||
| Bowel diameter >25 mm and/or feces sign | 1.27 | 0.853–1.905 | 0.26 | 1.01 | 0.99–1.02 | 0.402 |
| Beak sign and/or whirl sign and/or agglutinated bowel | 2.42 | 0.369–3.935 | 0.51 | 1.56 | 0.69–3.56 | 0.269 |
| Mesenteric edema | 0.48 | 0.31–1.24 | 0.67 | 1.01 | 0.61–1.64 | 0.615 |
| Total dose of radiotherapy | 0.89 | 0.61–1.14 | 0.07 | |||
| Successful GG challenge test | 3.58 | 2.83–5.54 | <0.001 | 1.15 | 0.52–2.51 | 0.803 |
| Duration of nasogastric tube decompression (>3 days) | 1.71 | 0.04–3.98 | 0.29 | 0.62 | 0.11–4.24 | 0.523 |
| Number of previous operations (>2) | 0.31 | 0.12–0.43 | 0.67 | 1.23 | 0.82–1.84 | 0.212 |
| Region of previous operation (upper abdomen) | 1.34 | 0.41–2.43 | 0.28 | 1.05 | 0.68–1.62 | 0.483 |
| Type of previous intra-abdominal operation | 2.08 | 0.47–3.80 | 0.21 | 1.50 | 0.76–2.97 | 0.229 |
| Previous episode of SBO | 2.3 | 0.74–3.60 | 0.23 | 1.27 | 0.64–2.48 | 0.438 |
| Previous operation for SBO | 0.27 | 0.14–0.34 | 0.01 | 0.96 | 0.51–1.87 | 0.756 |